Organic Light-Emitting Diodes Applications in Biomedical Therapy Mechanisms Clinical Studies and Challenges

Shuchen Sun

doi:10.54254/2755-2721/2025.GL27542

Applied and Computational EngineeringOpen access

Organic Light-Emitting Diodes Applications in Biomedical Therapy Mechanisms Clinical Studies and Challenges

Research Article

Open Access

Organic Light-Emitting Diodes Applications in Biomedical Therapy Mechanisms Clinical Studies and Challenges

Shuchen Sun ^1*

¹ Shanghai Datong High school

^*Corresponding author: susie0821ssc@gmail.com

Published on 2 October 2025

ACE Vol.187

ISSN (Print): 2755-273X

ISSN (Online): 2755-2721

ISBN (Print): 978-1-80590-393-2

ISBN (Online): 978-1-80590-394-9

Download Cover

Abstract

This paper mainly discusses the use of Organic Light-Emitting Diodes (OLEDs) in photodynamic therapy (PDT) and photobiomodulation (PBM) for curing typical basal cell carcinoma, Bowen disease, actinic keratosis. The innovative PDT method has several advantages than the traditional ones—OLEDs plays an essential role in reducing the pain for patients according to case studies and patients can barely experience uncomfortable feelings during the therapeutic process than before. It is also much more light-weighted and can be more closely attached to skin. Therefore, this device can also be applied to the elderly and infants at any location and at any time without going to the hospital. However, there are still some remaining issues such as the chronic pain, which is hard to be eliminated due to the conflict situation since reactive oxygen species (ROS) will cause major pain, however, if completely removing ROS will decrease the effect of PDT. Therefore, more researches need to be done in this field.

Keywords:

OLEDs, PDT, skin diseases

View PDF

References

[1]. Hauswald, S., Duque-Afonso, J., Wagner, M. M., Schertl, F. M., Lübbert, M., Peschel, C., et al. (2009). Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clinical Cancer Research, 15(11), 3705-3715.

[2]. Hagendoorn, J., Padera, T. P., Kashiwagi, S., Isaka, N., Noda, F., Lin, M. I., ... & Jain, R. K. (2004). Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circulation research, 95(2), 204-209.

[3]. Robertson, C. A., Evans, D. H., & Abrahamse, H. (2009). Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. Journal of Photochemistry and Photobiology B: Biology, 96(1), 1-8.

[4]. Wang, B., Shi, L., Zhang, Y. F., Zhou, Q., Zheng, J., Szeimies, R. M., & Wang, X. L. (2017). Gain with no pain? Pain management in dermatological photodynamic therapy. British Journal of Dermatology, 177(3), 656-665.

[5]. Eljamel, M. S., Goodman, C., & Moseley, H. (2008). ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: A single centre Phase III randomised controlled trial. Lasers in medical science, 23(4), 361-367.

[6]. DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., ... & Tuveson, D. A. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature, 475(7354), 106-109.

[7]. Bedard, K., & Krause, K. H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews, 87(1), 245-313.

[8]. Rai, P., Kumar, P. S., & Varadan, V. K. (2010, March). Integration of OLEDs in biomedical sensor systems: design and feasibility analysis. In Nanosensors, Biosensors, and Info-Tech Sensors and Systems 2010 (Vol. 7646, pp. 206-212). SPIE.

References

[7]. Bedard, K., & Krause, K. H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews, 87(1), 245-313.

Cite this article

Sun,S. (2025). Organic Light-Emitting Diodes Applications in Biomedical Therapy Mechanisms Clinical Studies and Challenges. Applied and Computational Engineering,187,31-34.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

About volume

Volume title: Proceedings of CONF-FMCE 2025 Symposium: Semantic Communication for Media Compression and Transmission

ISBN: 978-1-80590-393-2(Print) / 978-1-80590-394-9(Online)

Editor: Anil Fernando

Conference website: https://2025.conffmce.org/glasgow.html

Conference date: 24 October 2025

Series: Applied and Computational Engineering

Volume number: Vol.187

ISSN: 2755-2721(Print) / 2755-273X(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).